跳到正文
原文
Endpoints News 生物医药· Anna Brown·· 9 天前AI 评分35

VectorY 获 8350 万美元融资推进神经退行性疾病抗体基因疗法

VectorY bags $83.5M for antibody gene therapies in neurodegenerative diseases

AI 导读

VectorY 获得 8350 万美元融资,用于开发可在脑内生产抗体的基因疗法,针对神经退行性疾病。

正文

Vec­to­rY Ther­a­peu­tics added €74.5 mil­lion ($83.5 mil­lion) to its Se­ries A to fund a gene ther­a­py that makes an­ti­bod­ies in the brain.

The biotech’s lead …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news